Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
|Articles|April 22, 2020
COVID-19 Quick Clip: Access to Care
Behavioral health care providers are needed now more than ever to help support frontline caregivers and to provide access to care. Deena Tampi, MSN, MBA-HCA, offers insights about caring for the caregiver as well as providing access to care.
Advertisement
Behavioral health care providers are needed now more than ever to help support frontline caregivers and to provide access to care. Deena Tampi, MSN, MBA-HCA, offers insights about caring for the caregiver as well as providing access to care.
Ms Tampi is Executive Vice President,
Advertisement
Related to this article
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Advertisement
Advertisement
Trending on Psychiatric Times
1
ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials
2
Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment
3
From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry
4
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
5